| | | | | | | | | | | |  | | | | | | | | | | | | | | |  | | | | | | | | | | | | | | | | | Assessing Post-Cardiac Surgery Kidney Recovery Through PenKid's Emerging Role in Renal Replacement Therapy Decisions | | | | - Proenkephalin A 119-159 (penKid) demonstrates potential as a predictor for successful discontinuation of continuous renal replacement therapy (CRRT) in cardiac surgery patients.
- Study reveals significant differences in penKid levels between patients successfully and unsuccessfully liberated from CRRT.
- Findings suggest penKid could be a valuable tool in guiding CRRT liberation decisions.
Hennigsdorf/Berlin, Germany, January 9, 2025 - Diagnostic company SphingoTec GmbH ("SphingoTec") announces results from the first prospective study, conducted at the Medical University of Vienna, demonstrating penKid as a discriminatory biomarker for successful liberation from CRRT in cardiac surgery patients with acute kidney injury (AKI).
For more information, Prof. Bernardi will be discussing these findings and their implications in an upcoming webinar titled "Practice-Oriented Management of Acute Dialysis in Cardiac Surgery Patients: Strategies and Challenges in Clinical Practice." | | | | | | | | | | | | | | | | | | | Legal Notice
SphingoTec GmbH | Neuendorfstraße 15A | 16761 Hennigsdorf, Germany
Telephone + 49 (0)330 220 56 5-0 | info@sphingotec.com | www.sphingotec.com | | | | | | | | | | |
